Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Revicki

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
AIDS Care|September 24, 2004
Measuring validity of self-reported symptoms among people with HIVA W Wu, N B Dave, M Diener-West, et al.
JAMA|June 26, 1996
Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressantsG E Simon, M VonKorff, J H Heiligenstein, et al.
Pharmacoeconomics|February 7, 1994
Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepinE J Hatziandreu, R E Brown, D A Revicki, et al.
Pharmacoeconomics|November 4, 1995
Modelling the cost effectiveness of antidepressant treatment in primary careD A Revicki, R E Brown, W Palmer, et al.
Pharmacoeconomics|December 8, 1996
Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdosesD A Revicki, C S Palmer, S D Phillips, et al.
Annals of Emergency Medicine|May 1, 1994
Work-related stress and depression among practicing emergency physicians: an international studyT W Whitley, E J Allison, M E Gallery, et al.
Annals of Emergency Medicine|September 11, 1991
Work-related stress and depression among physicians pursuing postgraduate training in emergency medicine: an international studyT W Whitley, E J Allison, M E Gallery, et al.
Pharmacoeconomics|June 1, 2001
Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literatureA M Rentz, C Battista, E Trudeau, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1995
Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patientsD A Revicki, R E Brown, D H Feeny, et al.
The British Journal of Dermatology|October 2, 2013
Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom InventoryK B Gordon, A B Kimball, D Chau, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
AIDS Care|September 24, 2004
Measuring validity of self-reported symptoms among people with HIVA W Wu, N B Dave, M Diener-West, et al.
JAMA|June 26, 1996
Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressantsG E Simon, M VonKorff, J H Heiligenstein, et al.
Pharmacoeconomics|February 7, 1994
Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepinE J Hatziandreu, R E Brown, D A Revicki, et al.
Pharmacoeconomics|November 4, 1995
Modelling the cost effectiveness of antidepressant treatment in primary careD A Revicki, R E Brown, W Palmer, et al.
Pharmacoeconomics|December 8, 1996
Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdosesD A Revicki, C S Palmer, S D Phillips, et al.
Annals of Emergency Medicine|May 1, 1994
Work-related stress and depression among practicing emergency physicians: an international studyT W Whitley, E J Allison, M E Gallery, et al.
Annals of Emergency Medicine|September 11, 1991
Work-related stress and depression among physicians pursuing postgraduate training in emergency medicine: an international studyT W Whitley, E J Allison, M E Gallery, et al.
Pharmacoeconomics|June 1, 2001
Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literatureA M Rentz, C Battista, E Trudeau, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1995
Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patientsD A Revicki, R E Brown, D H Feeny, et al.
The British Journal of Dermatology|October 2, 2013
Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom InventoryK B Gordon, A B Kimball, D Chau, et al.
Pageof 12